42 Chapter 2 36. van Leeuwen AWFM, de Nooijer P, Hop WCJ. Screening for cervical carcinoma: Participation and results for ethnic groups and socioeconomic status. Cancer 2005; 105: 270-276. 37. Gok M, Heideman DAM, Van Kemenade FJ et al. Offering self-sampling for human papillomavirus testing to non-attendees of the cervical screening programme: Characteristics of the responders. European Journal of Cancer 2012; 48: 1799-1808. 38. Gok M, Heideman DAM, Van Kemenade FJ et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: Cohort study. BMJ (Online) 2010; 340: 905. 39. Hermens RPMG, Tacken MAJB, Hulscher MEJL et al. Attendance to cervical cancer screening in family practices in The Netherlands. Preventive Medicine: An International Journal Devoted to Practice and Theory 2000; 30: 35-42. 40. Bais AG, van Kemenade FJ, Berkhof J et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs. International Journal of Cancer 2007; 120: 1505-1510. 41. Bulkmans NWJ, Bulk S, Ottevanger MS et al. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate. Journal of Clinical Pathology 2006; 59: 1218-1220. 42. Woudstra AJ, Dekker E, Essink‐Bot ML, Suurmond J. Knowledge, attitudes and beliefs regarding colorectal cancer screening among ethnic minority groups in the Netherlands—A qualitative study. Health Expectations: An International Journal of Public Participation in Health Care & Health Policy 2016; 19: 1312-1323. 43. Toes-Zoutendijk E, van Leerdam ME, Dekker E et al. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. Gastroenterology 2017; 152: 767775.e762. 44. Knops-Dullens T, de Vries N, de Vries H. Reasons for non-attendance in cervical cancer screening programmes: an application of the Integrated Model for Behavioural Change. Eur J Cancer Prev 2007; 16: 436-445. 45. van Rijn AF, van Rossum LGM, Deutekom M et al. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test. Journal of Public Health 2008; 30: 461-465. 46. Hummel JM, Steuten LGM, Groothuis-Oudshoorn CJM et al. Preferences for colorectal cancer screening techniques and intention to attend: A multi-criteria decision analysis. Applied Health Economics and Health Policy 2013; 11: 499-507. 47. De Vries et al. Integrated Change Model 2004, 2005. Retrieved from: https://heindevries. eu/interests/change 48. Nierkens V, Stronks K, de Vries HJPm. Attitudes, social influences and self-efficacy expectations across different motivational stages among immigrant smokers: Replication of the∅ pattern. Preventive medicine 2006; 43: 306-311. 49. Hartman E, van den Muijsenbergh ME, Haneveld RW. Breast cancer screening participation among Turks and Moroccans in the Netherlands: exploring reasons for nonattendance. Eur J Cancer Prev 2009; 18: 349-353. 50. Bosgraaf RP, Siebers AG, de Hullu JA et al. The current position and the future perspectives of cervical cancer screening. Expert Review of Anticancer Therapy 2014; 14: 75-92. 51. Bekker MH, Lhajoui M. Health and literacy in first-and second-generation Moroccan Berber women in the Netherlands: Ill literacy? International Journal for Equity in Health 2004; 3: 8. 52. Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol 2017; 23: 3632-3642.
RkJQdWJsaXNoZXIy MTk4NDMw